List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Grand Yangtze Capital Investor

Grand Yangtze Capital is an investment firm focused principally on equity investments in growth and expansion stage enterprises in China. They have been managing 7 PE and VC funds since 2007 and have deployed over 4 billion RMB.

Grand Yangtze Capital has invested in over 40 companies, among which 8 companies went public, and several others were merged or acquired, e.g. Sino-Crystal (300064), Shuanghuan(002472), Hainan Rubber(601118), HLBN(300291), ZMJ(601717), China UMS, ZBT Pharma, ELLASSAY(603808), B-Soft(300451), Guochuang Software(300520), YMatou, Pharma Block, etc.


Invests into

Headquarters: Shanghai,Shanghai,China,Asia
Founded Date: 2006-01-01
Employee Number: 11-50
Investor Type: Venture Funds
Number Of Exists: 4
City: Shanghai
Region: Shanghai
Country: China
Funding Rounds: 37
Founders: Chunyi Li
Ipo Status: private